Compounds > zk 112993
Page last updated: 2024-09-03

zk 112993 and 8-bromo cyclic adenosine monophosphate

zk 112993 has been researched along with 8-bromo cyclic adenosine monophosphate in 3 studies

Compound Research Comparison

Studies
(zk 112993)		Trials
(zk 112993)		Recent Studies (post-2010)
(zk 112993)		Studies
(8-bromo cyclic adenosine monophosphate)		Trials
(8-bromo cyclic adenosine monophosphate)		Recent Studies (post-2010) (8-bromo cyclic adenosine monophosphate)
25003,7075198

Protein Interaction Comparison

ProteinTaxonomyzk 112993 (IC50)8-bromo cyclic adenosine monophosphate (IC50)
cAMP-specific 3',5'-cyclic phosphodiesterase 4AHomo sapiens (human)7.7
cAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)7.7
cAMP-specific 3',5'-cyclic phosphodiesterase 4CHomo sapiens (human)7.7
cAMP-specific 3',5'-cyclic phosphodiesterase 4DHomo sapiens (human)7.7

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Altmann, M; Beck, CA; DeMarzo, A; Edwards, DP; Weigel, NL; Zhang, Y1
Horwitz, KB; Sartorius, CA; Takimoto, GS; Tung, L1
Beck, CA; Edwards, DP; Moyer, ML; Nordeen, SK; Weigel, NL1

Other Studies

3 other study(ies) available for zk 112993 and 8-bromo cyclic adenosine monophosphate

ArticleYear
Progesterone receptor and the mechanism of action of progesterone antagonists.
    The Journal of steroid biochemistry and molecular biology, 1995, Volume: 53, Issue:1-6

    Topics: 8-Bromo Cyclic Adenosine Monophosphate; DNA-Binding Proteins; Estrenes; Gonanes; Humans; In Vitro Techniques; Mifepristone; Progesterone; Promegestone; Protein Binding; Protein Conformation; Receptors, Progesterone; Signal Transduction; Transcription Factors; Transcription, Genetic

1995
Antagonist-occupied human progesterone receptors bound to DNA are functionally switched to transcriptional agonists by cAMP.
    The Journal of biological chemistry, 1993, May-05, Volume: 268, Issue:13

    Topics: 8-Bromo Cyclic Adenosine Monophosphate; Animals; Antineoplastic Agents; Base Sequence; beta-Galactosidase; Breast Neoplasms; Cell Line; Chloramphenicol O-Acetyltransferase; Cyclic AMP; DNA-Binding Proteins; Female; Gonanes; Humans; Mifepristone; Molecular Sequence Data; Mutagenesis, Site-Directed; Oligodeoxyribonucleotides; Phosphates; Progesterone; Promegestone; Receptors, Progesterone; Recombinant Proteins; Transcription Factors; Transfection; Tumor Cells, Cultured

1993
The progesterone antagonist RU486 acquires agonist activity upon stimulation of cAMP signaling pathways.
    Proceedings of the National Academy of Sciences of the United States of America, 1993, May-15, Volume: 90, Issue:10

    Topics: 8-Bromo Cyclic Adenosine Monophosphate; Cyclic AMP; DNA-Binding Proteins; Gene Expression Regulation, Viral; Humans; In Vitro Techniques; Mammary Tumor Virus, Mouse; Mifepristone; Progesterone; Receptors, Progesterone; Signal Transduction; Transcription, Genetic; Tumor Cells, Cultured

1993